|
[1]
|
Bakhshimoghaddam, F. and Alizadeh, M. (2021) Contribution of Gut Microbiota to Nonalcoholic Fatty Liver Disease: Pathways of Mechanisms. Clinical Nutrition ESPEN, 44, 61-68. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Schupack, D.A., Mars, R.A.T., Voelker, D.H., et al. (2022) The Promise of the Gut Microbiome as Part of Individualized Treatment Strategies. Nature Reviews Gastroenterology & Hepatology, 19, 7-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Zhu, R., Lang, T., Yan, W., et al. (2021) Gut Microbiota: Influ-ence on Carcinogenesis and Modulation Strategies by Drug Delivery Systems to Improve Cancer Therapy. Advanced Science, 8, Article ID: 2003542. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Picardo, S.L., Coburn, B. and Hansen, A.R. (2019) The Microbiome and Cancer for Clinicians. Critical Reviews in Oncology/Hematology, 141, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Matson, V., Chervin, C.S. and Gajewski, T.F. (2021) Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy. Gas-troenterology, 160, 600-613. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Cuevas-Sierra, A., Ramos-Lopez, O., Riezu-Boj, J.I., et al. (2019) Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. Ad-vances in Nutrition, 10, S17-S30. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
王萍, 王颖, 万红, 段飞, 刘元炜, 陈玲, 郭盼盼, 燕树勋. 肠道菌群在代谢综合征发病机制中的作用[J]. 中国糖尿病杂志, 2020, 28(2): 147-149.
|
|
[8]
|
Ma, Q., Li, Y., Li, P., et al. (2019) Research Progress in the Relationship between Type 2 Diabetes Mellitus and Intestinal Flora. Biomedicine & Pharmacotherapy, 117, Article ID: 109138. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
梁磊, 念馨. 肠道菌群: 未来2型糖尿病治疗的新靶点[J]. 实用医学杂志, 2022, 38(3): 261-265.
|
|
[10]
|
辜雪莲, 李俊峰, 毛小荣. 肠道菌群在非酒精性脂肪性肝病中的研究进展[J]. 肝脏, 2021, 26(12): 1418-1420. [Google Scholar] [CrossRef]
|
|
[11]
|
熊晟均, 尹世章, 邓宛书, 赵元慧, 邢立莹, 孙英贤, 郭潇繁. 肠道菌群相关代谢产物与心血管疾病的关系研究进展[J]. 中国实用内科杂志, 2022, 42(2): 168-172.
|
|
[12]
|
Pluznick, J.L. (2016) Gut Microbiota in Renal Physiology: Focus on Short-Chain Fatty Acids and Their Receptors. Kidney International, 90, 1191-1198. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cui, L., Zhao, T., Hu, H., et al. (2017) Association Study of Gut Flora in Coronary Heart Disease through High- Throughput Sequencing. BioMed Research International, 2017, Article ID: 3796359. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Kain, V., Van Der Pol, W., Mariappan, N., et al. (2019) Obesogenic Diet in Aging Mice Disrupts Gut Microbe Composition and Alters Neutrophil: Lymphocyte Ratio, Leading to Inflamed Milieu in Acute Heart Failure. The FASEB Journal, 33, 6456-6469. [Google Scholar] [CrossRef]
|
|
[15]
|
郭风宜, 杨潇, 高天舒. 肠道菌群在自身免疫性疾病中的研究进展[J]. 国际免疫学杂志, 2021, 44(1): 91-96.
|
|
[16]
|
Vaghef-Mehrabany, E., Alipour, B., Homayouni-Rad, A., et al. (2014) Probiotic Supplementation Im-proves Inflammatory Status in Patients with Rheumatoid Arthritis. Nutrition, 30, 430-435. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
赵慧, 梁梅花. 肠道菌群对自身免疫性甲状腺疾病发病影响的研究进展[J]. 山东医药, 2021, 61(8): 105-108.
|
|
[18]
|
陶京瑞, 顿玲露, 卢昌均, 周哲屹. 多发性硬化与肠道菌群关系的研究进展[J]. 广西医学, 2021, 43(21): 2601-2604.
|
|
[19]
|
Miyake, S., Kim, S., Suda, W., et al. (2015) Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XI-Va and IV Clusters. PLoS ONE, 10, e0137429. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
陶燕, 李茂涓, 缪应雷. 基于炎症性肠病肠道菌群多组学特征的治疗策略[J]. 现代消化及介入诊疗, 2021, 26(9): 1174-1178.
|
|
[21]
|
Sankarasubramanian, J., Ahmad, R., Avuthu, N., et al. (2020) Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn’s Disease. Frontiers in Medi-cine, 7, Article ID: 606298. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
汤倩倩, 曹丽华. 肠道菌群与神经系统疾病[J]. 生物工程学报, 2021, 37(11): 3757-3780. [Google Scholar] [CrossRef] [PubMed]
|